Inovio Pharmaceuticals (INO)
(Delayed Data from NSDQ)
$10.57 USD
+0.45 (4.40%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $10.53 -0.04 (-0.38%) 7:58 PM ET
3-Hold of 5 3
F Value C Growth F Momentum F VGM
Brokerage Reports
0 items in cart
Inovio Pharmaceuticals, Inc. [INO]
Reports for Purchase
Showing records 361 - 363 ( 363 total )
Company: Inovio Pharmaceuticals, Inc.
Industry: Medical - Instruments
Therapeutic Cervical Cancer Vaccine Trial Fully Enrolled - $2.8 MM HCV Grant Obtained
Provider: RODMAN & RENSHAW, CO.
Analyst: BENJAMIN R
Company: Inovio Pharmaceuticals, Inc.
Industry: Medical - Instruments
MORNING SUMMARY
Provider: RODMAN & RENSHAW, CO.
Company: Inovio Pharmaceuticals, Inc.
Industry: Medical - Instruments
4Q09 UPDATE - CERVICAL CANCER VACCINE DATA TO DRIVE VALUE IN 2010
Provider: RODMAN & RENSHAW, CO.
Analyst: BENJAMIN R